Serum insulin and insulin-like growth factor-1 were significantly elevated in benign prostatic hyperplasia and prostate cancer group compared to controls with highest values in prostate cancer group (p-value <0.002 for insulin, <0.001 for insulin-like growth factor-1 and <0.014 for testosterone). This evidence concerns the gene INS and prostate carcinoma.